Targeting Cardiac Fibrosis with Chimeric Antigen Receptor Neutrophils Derived from Human Pluripotent Stem Cells
This study demonstrates that human pluripotent stem cell-derived neutrophils engineered with chimeric antigen receptors targeting fibroblast activation protein can selectively eliminate activated fibroblasts and improve cardiac function in a murine myocardial infarction model, offering a promising immunotherapeutic strategy for treating cardiac fibrosis.